Aster DM Healthcare Ltd.(IN:ASTERDM)
₹724.10-9.50 (-1.29%)
IN:ASTERDM
Aster DM Healthcare Ltd. financials statements
₹724.10
At close:-9.50 (-1.29%)
Want to see IN:ASTERDM full AI Analyst Report?
Aster DM Healthcare Ltd. (ASTERDM) Ratios
1 Followers
Aster DM Healthcare Ltd. Ratios
IN:ASTERDM's free cash flow for Q1 2027 was ₹0.00. For the 2027 fiscal year, IN:ASTERDM's free cash flow was increased by ₹0.00 and operating cash flow was ₹0.00. See a summary of the company’s cash flow.
| Ratios | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 1.99 | 2.16 | 1.25 | 1.06 | 1.15 |
| Quick Ratio | 1.90 | 2.06 | 1.24 | 0.75 | 0.86 |
| Cash Ratio | 1.35 | 1.57 | 0.01 | 0.08 | 0.10 |
| Solvency Ratio | 0.20 | 1.90 | 0.02 | 0.06 | 0.11 |
| Operating Cash Flow Ratio | 0.68 | 0.48 | 0.01 | 0.39 | 0.37 |
| Short-Term Operating Cash Flow Coverage | 3.89 | 2.68 | 0.71 | 1.88 | 1.81 |
| Net Current Asset Value | ₹ -13.30B | ₹ -10.53B | ₹ 12.04B | ₹ -50.99B | ₹ -39.67B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.27 | 0.31 | 0.08 | 0.38 | 0.39 |
| Debt-to-Equity Ratio | 0.49 | 0.59 | 0.30 | 1.28 | 1.24 |
| Debt-to-Capital Ratio | 0.33 | 0.37 | 0.23 | 0.56 | 0.55 |
| Long-Term Debt-to-Capital Ratio | 0.11 | 0.12 | 0.09 | 0.23 | 0.27 |
| Financial Leverage Ratio | 1.77 | 1.93 | 3.95 | 3.35 | 3.17 |
| Debt Service Coverage Ratio | 2.76 | 2.38 | 1.39 | 0.35 | 1.14 |
| Interest Coverage Ratio | 5.18 | 3.96 | 8.34 | 8.37 | 8.44 |
| Debt to Market Cap | 0.02 | 0.03 | 0.03 | 0.05 | 0.22 |
| Interest Debt Per Share | 45.45 | 43.18 | 28.60 | 29.81 | 104.78 |
| Net Debt to EBITDA | 0.93 | 0.77 | 2.44 | 12.98 | 3.77 |
| Profitability Margins | |||||
| Gross Profit Margin | 30.64% | 76.94% | 53.42% | 52.06% | 35.77% |
| EBIT Margin | 14.92% | 14.22% | 9.68% | 8.59% | 8.23% |
| EBITDA Margin | 20.61% | 20.33% | 14.41% | 13.70% | 11.81% |
| Operating Profit Margin | 13.71% | 12.91% | 26.84% | 26.84% | 25.26% |
| Pretax Profit Margin | 12.27% | 11.58% | 7.06% | 6.53% | 6.21% |
| Net Profit Margin | 8.36% | 132.15% | 3.50% | 14.19% | 5.13% |
| Continuous Operations Profit Margin | 9.20% | 8.27% | 5.53% | 5.33% | 5.86% |
| Net Income Per EBT | 68.13% | 1141.64% | 49.50% | 217.39% | 82.59% |
| EBT Per EBIT | 89.46% | 89.64% | 26.31% | 24.32% | 24.59% |
| Return on Assets (ROA) | 4.78% | 81.40% | 0.72% | 2.86% | 4.19% |
| Return on Equity (ROE) | 8.48% | 156.88% | 2.84% | 9.55% | 13.30% |
| Return on Capital Employed (ROCE) | 8.93% | 9.18% | 14.81% | 7.86% | 28.82% |
| Return on Invested Capital (ROIC) | 6.54% | 6.35% | 11.19% | 5.73% | 24.56% |
| Return on Tangible Assets | 4.96% | 85.20% | 0.73% | 3.18% | 4.70% |
| Earnings Yield | 1.12% | 22.52% | 0.60% | 0.91% | 5.35% |
| Efficiency Ratios | |||||
| Receivables Turnover | 15.11 | 15.78 | 13.98 | 1.25 | 4.98 |
| Payables Turnover | 6.69 | 2.20 | 3.76 | 0.48 | 3.11 |
| Inventory Turnover | 35.33 | 10.16 | 12.52 | 1.02 | 6.42 |
| Fixed Asset Turnover | 1.06 | 1.04 | 1.21 | 0.38 | 1.54 |
| Asset Turnover | 0.57 | 0.62 | 0.21 | 0.20 | 0.82 |
| Working Capital Turnover Ratio | 4.66 | 2.09 | 2.35 | 7.45 | 21.11 |
| Cash Conversion Cycle | -20.09 | -106.73 | -41.91 | -109.78 | 12.82 |
| Days of Sales Outstanding | 24.15 | 23.12 | 26.11 | 290.85 | 73.36 |
| Days of Inventory Outstanding | 10.33 | 35.92 | 29.14 | 359.21 | 56.85 |
| Days of Payables Outstanding | 54.57 | 165.78 | 97.17 | 759.84 | 117.39 |
| Operating Cycle | 34.48 | 59.04 | 55.26 | 650.06 | 130.21 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 13.01 | 8.54 | 3.00 | 9.43 | 26.39 |
| Free Cash Flow Per Share | 3.91 | 1.59 | -12.16 | 5.07 | 15.38 |
| Dividend Paid and CapEx Coverage Ratio | 1.29 | 0.07 | 0.20 | 2.16 | 2.40 |
| Capital Expenditure Coverage Ratio | 1.43 | 1.23 | 0.20 | 2.16 | 2.40 |
| Operating Cash Flow Coverage Ratio | 0.30 | 0.21 | 0.11 | 0.32 | 0.27 |
| Operating Cash Flow to Sales Ratio | 0.14 | 0.10 | 0.04 | 0.61 | 0.13 |
| Free Cash Flow Yield | 0.58% | 0.33% | -2.98% | 2.11% | 7.79% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 88.98 | 4.44 | 165.85 | 110.14 | 18.68 |
| Price-to-Sales (P/S) Ratio | 7.44 | 5.87 | 5.80 | 15.63 | 0.96 |
| Price-to-Book (P/B) Ratio | 7.55 | 6.97 | 4.70 | 10.52 | 2.49 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 171.46 | 302.26 | -33.55 | 47.48 | 12.84 |
| Price-to-Operating Cash Flow Ratio | 51.51 | 56.19 | 135.87 | 25.52 | 7.48 |
| Price-to-Earnings Growth (PEG) Ratio | -0.96 | 0.00 | 13.45 | -1.39 | 0.07 |
| Enterprise Value Multiple | 37.03 | 29.63 | 42.67 | 127.09 | 11.88 |
| Enterprise Value | 354.30B | 245.19B | 227.43B | 521.22B | 143.92B |
| EV to EBITDA | 37.03 | 29.63 | 42.67 | 127.09 | 11.88 |
| EV to Sales | 7.63 | 6.03 | 6.15 | 17.41 | 1.40 |
| EV to Free Cash Flow | 175.90 | 310.33 | -35.59 | 52.88 | 18.80 |
| EV to Operating Cash Flow | 52.84 | 57.69 | 144.12 | 28.42 | 10.96 |
| Tangible Book Value Per Share | 88.14 | 67.41 | 90.10 | 17.14 | 62.63 |
| Shareholders’ Equity Per Share | 88.77 | 68.84 | 86.78 | 22.88 | 79.45 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.25 | 0.29 | 0.22 | 0.18 | 0.06 |
| Revenue Per Share | 90.08 | 81.72 | 70.39 | 15.40 | 206.04 |
| Net Income Per Share | 7.53 | 107.99 | 2.46 | 2.19 | 10.57 |
| Tax Burden | 0.68 | 11.42 | 0.49 | 2.17 | 0.83 |
| Interest Burden | 0.82 | 0.81 | 0.73 | 0.76 | 0.75 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.17 | 0.27 | 0.22 | 0.22 | 0.08 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | -0.00 |
| Income Quality | 1.73 | 1.39 | 1.22 | 3.43 | 2.06 |
Currency in INR

